Zhang Yi-Fan, Ho Mitchell
a Laboratory of Molecular Biology , National Cancer Institute , Bethesda , MD , USA.
MAbs. 2017 Apr;9(3):419-429. doi: 10.1080/19420862.2017.1289302. Epub 2017 Feb 6.
Rabbit monoclonal antibodies (RabMAbs) can recognize diverse epitopes, including those poorly immunogenic in mice and humans. However, there have been only a few reports on RabMAb humanization, an important antibody engineering step usually done before clinical applications are investigated. To pursue a general method for humanization of RabMAbs, we analyzed the complex structures of 5 RabMAbs with their antigens currently available in the Protein Data Bank, and identified antigen-contacting residues on the rabbit Fv within the 6 Angstrom distance to its antigen. We also analyzed the supporting residues for antigen-contacting residues on the same heavy or light chain. We identified "HV4" and "LV4" in rabbit Fvs, non-complementarity-determining region (CDR) loops that are structurally close to the antigen and located in framework 3 of the heavy chain and light chain, respectively. Based on our structural and sequence analysis, we designed a humanization strategy by grafting the combined Kabat/IMGT/Paratome CDRs, which cover most antigen-contacting residues, into a human germline framework sequence. Using this strategy, we humanized 4 RabMAbs that recognize poorly immunogenic epitopes in the cancer target mesothelin. Three of the 4 humanized rabbit Fvs have similar or improved functional binding affinity for mesothelin-expressing cells. Interestingly, 4 immunotoxins composed of the humanized scFvs fused to a clinically used fragment of Pseudomonas exotoxin (PE38) showed stronger cytotoxicity against tumor cells than the immunotoxins derived from their original rabbit scFvs. Our data suggest that grafting the combined Kabat/IMGT/Paratome CDRs to a stable human germline framework can be a general approach to humanize RabMAbs.
兔单克隆抗体(RabMAbs)能够识别多种表位,包括那些在小鼠和人类中免疫原性较差的表位。然而,关于RabMAb人源化的报道仅有少数几篇,而人源化是抗体工程中的一个重要步骤,通常在开展临床应用研究之前进行。为了探寻一种通用的RabMAb人源化方法,我们分析了5种RabMAb与其抗原的复杂结构,这些结构目前可在蛋白质数据库中获取,并确定了兔Fv中与抗原距离在6埃以内的抗原接触残基。我们还分析了同一重链或轻链上抗原接触残基的支持残基。我们在兔Fv中鉴定出“HV4”和“LV4”,它们是非互补决定区(CDR)环,在结构上靠近抗原,分别位于重链和轻链的框架3中。基于我们的结构和序列分析,我们设计了一种人源化策略,即将覆盖大多数抗原接触残基的组合Kabat/IMGT/Paratome CDR嫁接到人胚系框架序列中。利用这一策略,我们对4种识别癌症靶点间皮素中免疫原性较差表位的RabMAb进行了人源化。4种人源化兔Fv中的3种对表达间皮素的细胞具有相似或更高的功能性结合亲和力。有趣的是,由人源化单链抗体片段(scFvs)与临床使用的铜绿假单胞菌外毒素片段(PE38)融合而成的4种免疫毒素,对肿瘤细胞的细胞毒性比源自其原始兔scFv的免疫毒素更强。我们的数据表明,将组合Kabat/IMGT/Paratome CDR嫁接到稳定的人胚系框架上可能是一种通用的RabMAb人源化方法。